SMMT
Price
$22.66
Change
-$0.68 (-2.91%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
17.34B
27 days until earnings call
STRO
Price
$0.86
Change
+$0.01 (+1.18%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
72.37M
27 days until earnings call
Interact to see
Advertisement

SMMT vs STRO

Header iconSMMT vs STRO Comparison
Open Charts SMMT vs STROBanner chart's image
Summit Therapeutics
Price$22.66
Change-$0.68 (-2.91%)
Volume$31.44K
Capitalization17.34B
Sutro Biopharma
Price$0.86
Change+$0.01 (+1.18%)
Volume$21.68K
Capitalization72.37M
SMMT vs STRO Comparison Chart in %
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMMT vs. STRO commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMT is a StrongBuy and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (SMMT: $22.65 vs. STRO: $0.86)
Brand notoriety: SMMT and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SMMT: 44% vs. STRO: 114%
Market capitalization -- SMMT: $17.34B vs. STRO: $72.37M
SMMT [@Biotechnology] is valued at $17.34B. STRO’s [@Biotechnology] market capitalization is $72.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMT’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • SMMT’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMT’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 4 bullish TA indicator(s).

  • SMMT’s TA Score: 4 bullish, 5 bearish.
  • STRO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than STRO.

Price Growth

SMMT (@Biotechnology) experienced а +8.53% price change this week, while STRO (@Biotechnology) price change was -5.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.88%. For the same industry, the average monthly price growth was +22.21%, and the average quarterly price growth was +89.30%.

Reported Earning Dates

SMMT is expected to report earnings on Nov 05, 2025.

STRO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+8.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($17.3B) has a higher market cap than STRO($72.4M). SMMT YTD gains are higher at: 30.793 vs. STRO (-53.603). STRO has higher annual earnings (EBITDA): -164.93M vs. SMMT (-743.48M). SMMT has more cash in the bank: 298M vs. STRO (205M). SMMT has less debt than STRO: SMMT (5.55M) vs STRO (19.6M). STRO has higher revenues than SMMT: STRO (104M) vs SMMT (0).
SMMTSTROSMMT / STRO
Capitalization17.3B72.4M23,895%
EBITDA-743.48M-164.93M451%
Gain YTD30.793-53.603-57%
P/E Ratio26.36N/A-
Revenue0104M-
Total Cash298M205M145%
Total Debt5.55M19.6M28%
FUNDAMENTALS RATINGS
SMMT vs STRO: Fundamental Ratings
SMMT
STRO
OUTLOOK RATING
1..100
1660
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
43100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
8100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRO's Valuation (18) in the Pharmaceuticals Major industry is significantly better than the same rating for SMMT (94) in the Biotechnology industry. This means that STRO’s stock grew significantly faster than SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (43) in the Biotechnology industry is somewhat better than the same rating for STRO (100) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew somewhat faster than STRO’s over the last 12 months.

SMMT's SMR Rating (100) in the Biotechnology industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew similarly to STRO’s over the last 12 months.

SMMT's Price Growth Rating (62) in the Biotechnology industry is in the same range as STRO (63) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew similarly to STRO’s over the last 12 months.

SMMT's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for STRO (100) in the Pharmaceuticals Major industry. This means that SMMT’s stock grew significantly faster than STRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMMTSTRO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPAEF22.86N/A
N/A
Grupo Aeroportuario del Pacifico S.A.B. de CV
PXXLF0.25N/A
N/A
Poxel SA
INVUP25.44N/A
N/A
Investview Inc.
NASB35.14-0.11
-0.32%
NASB Financial, Inc.
APNHY5.55-0.07
-1.25%
Aspen Pharmacare Holdings plc

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+4.71%
BCDA - SMMT
70%
Closely correlated
+7.58%
BNTX - SMMT
49%
Loosely correlated
+0.21%
TIL - SMMT
49%
Loosely correlated
+10.50%
IDYA - SMMT
43%
Loosely correlated
-0.30%
MGNX - SMMT
42%
Loosely correlated
+3.49%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with TIL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+1.35%
TIL - STRO
40%
Loosely correlated
+10.50%
GLSI - STRO
40%
Loosely correlated
+1.91%
BEAM - STRO
39%
Loosely correlated
+7.44%
TCRX - STRO
38%
Loosely correlated
+0.51%
SMMT - STRO
38%
Loosely correlated
+4.71%
More